Skip to main content
. 2021 Aug 24;10(17):3777. doi: 10.3390/jcm10173777

Table 5.

Allele and genotype distribution for the NOD2 c.3020insC (p.1007fs rs5743293) variant.

c.3020insC (p.1007fs)
rs5743293
Genotypes
n (%)
Alleles
n (%)
Group n insC/insC -/insC -/- - insC
IBD whole group * 573 39 (6.8%) 90 (15.7%) 444 (77.5%) 978 (85.3%) 168 (14.7%)
UC adults * 210 6 (2.9%) 20 (9.5%) 184 (87.6%) 388 (92.4%) 32 (7.6%)
UC adult women * 98 4 (4.1%) 4 (4.1%) 90 (91.8%) 184 (93.9%) 12 (6.1%)
UC adult men 112 2 (1.8%) 16 (14.3%) 94 (83.9%) 204 (91.1%) 20 (8.9%)
UC children 64 1 (1.6%) 11 (17.2%) 52 (81.2%) 115 (89.8%) 13 (10.2%)
UC girls 27 1 (3.7%) 4 (14.8%) 22 (81.5%) 48 (88.9%) 6 (11.1%)
UC boys 37 n.o. 7 (19.9%) 30 (81.1%) 67 (90.5%) 7 (9.5%)
UC whole group * 274 7 (2.6%) 31 (11.3%) 236 (86.1%) 503 (91.8%) 45 (8.2%)
CD adults * 215 25 (11.6%) 48 (22.3%) 142 (66.1%) 332 (77.2%) 98 (22.8%)
CD adult women * 117 11 (9.4%) 21 (17.9%) 85 (72.7%) 191 (81.6%) 43 (18.4%)
CD adult men * 98 14 (14.3%) 27 (27.5%) 57 (58.2%) 141 (71.9%) 55 (28.1%)
CD children * 84 7 (8.3%) 11 (13.1%) 66 (78.6%) 143 (85.1%) 25 (14.9%)
CD girls * 40 3 (7.5%) 4 (10%) 33 (82.5%) 70 (87.5%) 10 (12.5%)
CD boys * 44 4 (9.1%) 7 (15.9%) 33 (75%) 73 (83%) 15 (17%)
CD whole group * 299 32 (10.7%) 59 (19.7%) 208 (69.6%) 475 (79.4%) 123 (20.6%)
Controls 888 n.o. 73 (8.2%) 815 (91.8%) 73 (4.1%) 1703 (95.9%)
(insC/insC) vs. (-/-)
OR
95% CI
p-value
(insC/-) vs. (-/-)
OR
95% CI
p-value
(insC/insC) + (insC/-) vs. (-/-)
OR
95% CI
p-value
(insC) vs. (-)
OR
95% CI
p-value
IBD vs. controls OR = 64.16
CI = (8.38–2228.16)
p < 0.001
OR = 2.26
CI = (1.63–3.15)
p < 0.001
OR = 3.24
CI = (2.38–4.42)
p < 0.001
OR = 3.01
CI = (3.01–5.33)
p < 0.001
UC adults vs. controls OR = 57.46
CI = (3.22–1024.52)
p < 0.001
OR = 1.21
CI = (0.72–2.04)
p = 0.465
OR = 1.58
CI = (0.98–2.54)
p = 0.058
OR = 1.92
CI = (1.25–2.96)
p = 0.002
UC children vs. controls OR = 46.60
CI = (1.87–1157.89)
p < 0.001
OR = 2.36
CI = (1.18–4.72)
p = 0.013
OR = 2.58
CI = (1.32–5.04)
p = 0.004
OR = 2.64
CI = (1.42–4.90)
p = 0.001
UC adults vs. UC children OR = 1.70
CI = (0.20–14.40)
p = 0.625
OR = 0.51
CI = (0.23–1.41)
p = 0.097
OR = 0.61
CI = (0.29–1.30)
p = 0.197
OR = 0.73
CI = (0.37–1.44)
p = 0.360
UC women vs. UC men OR = 2.10
CI = (0.37–11.69)
p = 0.392
OR = 0.26
CI = (0.08–0.81)
p = 0.014
OR = 0.46
CI = (0.19–1.12)
p = 0.083
OR = 0.67
CI = (0.32–1.40)
p = 0.280
UC girls vs. UC boys OR = 4.07
CI = (0.16–104.53)
p = 0.249
OR = 0.78
CI = (0.20–2.99)
p = 0.716
OR = 0.97
CI = (2.84–3.48)
p = 0.968
OR = 1.20
CI = (0.38–3.79)
p = 0.760
UC whole group vs. controls OR = 51.72
CI = (2.94–908.93)
p < 0.001
OR = 1.47
CI = (0.94–3.29)
p = 0.090
OR = 1.80
CI = (0.18–2.73)
p = 0.005
OR = 2.09
CI = (1.42–3.07)
p < 0.001
CD adults vs. controls OR = 291.86
CI = (17.67–4821.24)
p < 0.001
OR = 3.77
CI = (2.52–5.66)
p < 0.001
OR = 5.74
CI = (3.96–8.31)
p < 0.001
OR = 6.89
CI = (4.98–9.53)
p < 0.001
CD children vs. controls OR = 183.95
CI = (10.39–3255.99)
p < 0.001
OR = 1.86
CI = (0.94–3.70)
p = 0.070
OR = 3.05
CI = (1.72–5.40)
p < 0.001
OR = 4.08
CI = (2.51–6.63)
p < 0.001
CD adults vs. CD children OR = 1.66
CI = (0.68–4.03)
p = 0.259
OR = 2.03
CI = (0.99–4.16)
p = 0.050
OR = 1.86
CI = (1.04–3.41)
p = 0.034
OR = 1.69
CI = (1.04–2.73)
p = 0.032
CD women vs. CD men OR = 0.53
CI = (0.22–1.24)
p = 0.139
OR = 0.52
CI = (0.27–1.01)
p = 0.052
OR = 0.52
CI = (0.30–0.93)
p = 0.026
OR = 0.58
CI = (0.37–0.91)
p = 0.017
CD girls vs. CD boys OR = 0.75
CI = (0.16–3.62)
p = 0.719
OR = 0.57
CI = (0.15–2.14)
p = 0.402
OR = 0.64
CI = (0.22–1.84)
p = 0.402
OR = 0.70
CI = (0.29–1.65)
p = 0.408
CD whole group vs. controls OR = 254.23
CI = (15.50–4169.02)
p < 0.001
OR = 3.17
CI = (2.18–4.61)
p < 0.001
OR = 4.88
CI = (3.46–6.89)
p < 0.001
OR = 6.04
CI = (4.44–8.21)
p < 0.001
CD whole group vs. UC whole group OR = 5.19
CI = (2.24–12.00)
p < 0.001
OR = 2.16
CI = (1.35–3.47)
p = 0.001
OR = 2.72
CI = (1.78–4.14)
p < 0.001
OR = 2.89
CI = (2.01–4.16)
p < 0.001

Statistically significant results are marked in bold; n.o.: not observed; *: deviation from HWE.